ArticleNature communications2017

Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma.

Aviram Mizrachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.